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Abstract
Introduction: Severe sepsis is a disease of the microcirculation, with endothelial dysfunction playing a key role in its 
pathogenesis and subsequent associated mortality. Angiogenesis in damaged small vessels may ameliorate this 
dysfunction. The aim of the study was to determine whether the angiogenic factors (vascular endothelial growth factor 
(VEGF), platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), and angiopoietin-1 (Ang-1) and -2 (Ang-
2)) are mortality indicators in Malawian children with severe bacterial infection.
Methods: In 293 children with severe bacterial infection, plasma VEGF, PDGF, FGF, and Ang-1 and Ang-2 were 
measured on admission; in 50 of the children with meningitis, VEGF, PDGF, and FGF were also measured in the CSF. 
Healthy controls comprised children from some of the villages of the index cases. Univariable and multivariable logistic 
regression analyses were performed to develop a prognostic model.
Results: The median age was 2.4 years, and the IQR, 0.7 to 6.0 years. There were 211 children with bacterial meningitis 
(72%) and 82 (28%) with pneumonia, and 154 (53%) children were HIV infected. Mean VEGF, PDGF, and FGF 
concentrations were higher in survivors than in nonsurvivors, but only PDGF remained significantly increased in 
multivariate analysis (P = 0.007). Mean Ang-1 was significantly increased, and Ang-2 was significantly decreased in 
survivors compared with nonsurvivors (6,000 versus 3,900 pg/ml, P = 0.03; and 7,700 versus 11,900 pg/ml, P = 0.02, 
respectively). With a logistic regression model and controlling for confounding factors, only female sex (OR, 3.95; 95% 
CI, 1.33 to 11.76) and low Ang-1 (OR, 0.23; 95% CI, 0.08 to 0.69) were significantly associated with mortality. In children 
with bacterial meningitis, mean CSF VEGF, PDGF, and FGF concentrations were higher than paired plasma 
concentrations, and mean CSF, VEGF, and FGF concentrations were higher in nonsurvivors than in survivors (P = 0.02 
and 0.001, respectively).
Conclusions: Lower plasma VEGF, PDGF, FGF, and Ang-1 concentrations and higher Ang-2 concentrations are 
associated with an unfavorable outcome in children with severe bacterial infection. These angiogenic factors may be 
important in the endothelial dysregulation seen in severe bacterial infection, and they could be used as biomarkers for 
the early identification of patients at risk of a poor outcome.
Introduction
Sepsis remains a leading cause of death in children in the
developing world, accounting for some 60% of childhood
mortality.  Streptococcus pneumoniae and  Haemophilus
influenzae  type b, two pathogens responsible for most
childhood deaths of pneumonia and bacterial meningitis,
caused more than a million deaths globally in children
younger than 5 years in 2000 [1,2]. Severe sepsis is a dis-
ease of the microcirculation, with endothelial dysfunction
playing a key role in its pathogenesis and subsequent
associated mortality [3]. Endothelial progenitor cells
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from the bone marrow ameliorate the dysfunction caused
by severe sepsis, and this process is thought to be medi-
ated by angiogenesis in ischemic areas and in damaged
small vessels [4,5].
Growth factors are recognized for their ability to
induce cellular proliferation and differentiation. Vascular
endothelial growth factor (VEGF), a dimeric 46-kDa gly-
coprotein, is an endothelial cell-specific, multifunctional
cytokine. VEGF is a potent regulator of vascular permea-
bility and angiogenesis, and in endothelial cells, induces
the expression of cell-adhesion molecules and the release
of cytokines and chemokines [6,7]. Platelet-derived
growth factor (PDGF) has angiogenic effects and stimu-
lates endothelial cell migration [8,9]. Despite the name
"platelet derived," studies suggest that the endothelium
rather than platelets might be a major source of PDGF in
sepsis [10]. Fibroblast growth factor (FGF) promotes
angiogenesis and also has antiapoptotic effects [11,12].
Elevated CSF levels of FGF have been observed in chil-
dren with bacterial meningitis and are associated with
poor outcome, suggesting neurotropic effects [13].
The angiopoietins, angiopoietin-1 (Ang-1) and angio-
poietin-2 (Ang-2), play a fundamental role in the mainte-
nance of vessel integrity. Angiopoietin-1 (Ang-1) and
Ang-2 are ligands of the endothelial receptor tyrosine
kinase Tie-2, which is a key regulator of endothelial func-
tion [14]. Binding of circulating Ang-1 to the Tie-2 recep-
tor protects the vasculature from inflammation and
leakage, whereas binding of Ang-2 antagonizes Tie-2 sig-
naling and disrupts endothelial barrier function. Ang-1 is
important for blood vessel stability, inhibiting vascular
leakage, and suppressing inflammatory gene expression
[15,16]. Ang-2 is generally an antagonist of Ang-1, but in
the presence of VEGF, promotes cell survival [17]. Both
Ang-1 and VEGF concentrations have been reported to
be significantly lower in patients with sepsis than in con-
trols, but Ang-2 levels are higher and are associated with
disease severity [18,19]. PDGF stimulation of vascular
smooth muscle cells leads to a decrease in Ang-2 levels
[20]. Elevated Ang-2 levels have been reported in severe
sepsis and septic shock and may contribute to sepsis-
related capillary leak [19,21-23].
Clinical data from adult studies [24-28] support the
association of elevated plasma growth factor concentra-
tions with sepsis. Studies in children have demonstrated
increased plasma VEGF concentrations in meningococ-
cal sepsis [29] and community-acquired pneumonia [30],
and increased plasma PDGF and VEGF in respiratory
syncytial virus infection [31], but these three growth fac-
tors together with Ang-1 and Ang-2 have never previ-
ously been explored in a large study in children. Given
that the angiogenic factors have been identified as predic-
tors of disease severity in sepsis, we aimed to determine
whether the five angiogenic factors (PDGF, VEGF, FGF,
and Ang-1 and Ang-2) may be mortality indicators in a
population with a high burden of parasitic and HIV infec-
tion. We also aimed to investigate whether evidence
exists of a relation between intracerebral production of
angiogenic factors and mortality in bacterial meningitis.
We selected three growth factors and two angiopoietins
in an attempt to understand whether they may play a role
in the mobilization of endothelial progenitor cells in
severe bacterial infection.
Materials and methods
Ethics statement
Ethical approval for this study was granted from The Col-
l e g e  o f  M e d i c i n e  R e s e a r c h  C o m m i t t e e  ( C O M R E C ) ,
Malawi, and The Liverpool School of Tropical Medicine
Local Research Ethics Committee. Parents or guardians
gave written informed consent for children to enter the
study.
Study population
The study was part of a larger prospective observational
study investigating the genetic susceptibility to invasive
pneumococcal disease in Malawian children [32]. This
study was conducted at Queen Elizabeth Central Hospital
(QECH) in Blantyre, Malawi, between April 2004 and
October 2006. We recruited children aged between 2
months and 16 years with a suspected diagnosis of bacte-
rial meningitis or pneumonia. Details on enrolment crite-
ria, laboratory methods, and management protocols were
described elsewhere [33]. We also collected data on the
duration of symptoms and on previous antibiotic admin-
istration. As our previous data indicated that these fac-
tors did not influence outcome in multivariate analysis,
we did not include them in the analysis reported here
[33]. We recorded the Blantyre Coma Score (BCS) on
admission [34]; this has a scale from 0 to 5, with a score of
≤2 defining coma. We assessed each child's nutritional
status by using weight-for-height Z scores and height-for-
age Z scores. In total, we recruited 377 children to the
parent study, but angiogenic factor determination was
performed on only the first 293 cases, who constituted
the study population of the present investigation. Pneu-
mococcal bacterial loads were determined as previously
described [33].
We used the following definitions:
Cases  (n = 293): Children first seen with signs and
symptoms of bacterial meningitis or pneumonia in whom
growth factors were determined. 
Healthy controls (n = 15): Healthy afebrile children
from the same villages as the cases, who had no malarial
parasites on blood film. Controls were selected by parents
or guardians in the neighborhood of the index case as
part of a larger study investigating genetic susceptibility
in IPD [32]. In a small number of children, parental con-Mankhambo et al. Critical Care 2010, 14:R91
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sent also was given to take venous samples for cytokine
and angiogenic factor determination. 
Invasive pneumococcal disease (IPD) (n = 180): S. pneu-
moniae was identified (by culture, microscopy, and Gram
stain, antigen testing, or PCR) from one or more of the
following normally sterile body sites: blood, cerebrospinal
fluid, lung aspirate.
Serious bacterial infection (SBI) (n = 216): Children
with bacterial meningitis or pneumonia, and in whom a
bacterial pathogen was identified by culture, polysaccha-
ride antigen test, or PCR in blood, cerebrospinal fluid or
lung aspirate fluid (Streptococcus pneumoniae, Neisseria
meningitidis, and Haemophilus influenzae b).
No detectable bacterial infection (NBI) (n = 77): Chil-
dren with bacterial meningitis or pneumonia, but who
were negative for any bacteria on culture, polysaccharide
antigen test, or PCR (S. pneumoniae, N. meningitidis, and
H. influenzae b). 
Pneumonia (n = 82): Confirmed by radiology and posi-
tive blood or lung aspirate by culture or PCR. 
Bacterial meningitis (n = 211): Confirmed by CSF cell
count (>10 per microliter) and one of the following tests:
CSF culture, Gram stain, polysaccharide antigen, or PCR
positive.
Growth factor, Ang-1, and Ang-2 determination
Growth-factor determination was performed in plasma
and CSF samples by using Luminex 100 technology in the
Bio-plex Protein Array System (Bio-Rad Laboratories.
Inc., Santa Clara, California, USA) by using a 27-plex Bio-
plex Human Cytokine kit, which includes IL-1β, IL-1ra,
IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12 (p70),
IL-13, IL-15, IL-17, eotaxin, basic FGF, G-CSF, GM-CSF,
IFN-γ, IP-10, MCP-1 (MCAF), MIP-1α, MIP-1β, PDGF-
BB, RANTES, TNF-α, and VEGF (Bio-Rad Laboratories),
according to the manufacturer's instructions. In 50 chil-
dren with bacterial meningitis, in whom sufficient CSF
existed for analysis, CSF growth factors were determined
on admission. Plasma Ang-1 and Ang-2 were determined
by using a commercial ELISA assay (R&D Systems
Europe, Ltd., Abingdon, UK). We have previously
reported the analysis of chemokines and pro-and antiin-
flammatory cytokines in this cohort [33,35].
HIV determination
HIV status was assessed in children 18 months or older
by using at least two of the following tests; Unigold and
Serocard (T rinity Biotech, W icklow , Ireland), or Deter -
mine-HIV (Abbott Laboratories, Springfield, IL, USA).
At least two tests were required to be positive for a sub-
ject to be classified as HIV infected. In children younger
than 18 months, and in those with discordant antibody
tests, HIV status was determined by using Amplicor HIV-
1 DNA Test version 1.5 (Roche Diagnostics, South San
Francisco, CA, USA).
Statistical analysis
The growth factors and angiopoietins determined were
summarized by using geometric means and interquartile
ranges (IQRs). Two-sample t tests were used to compare
growth-factor concentrations between groups, by using
log-transformed data. Multiway analyses of variance were
used to obtain adjusted comparisons for each factor of
interest (main effects: SBI/NBI, pneumonia/meningitis,
HIV status, survivor/nonsurvivor, and gram positive/neg-
ative infection). Correlations between growth factors and
other variables were estimated by using Spearman's rho
correlation coefficient. Fisher's Exact test was used to
compare proportions. Univariable and multivariable
logistic regression analyses were performed to develop a
prognostic model of the influence of confounding factors
(HIV status, age, sex, diagnosis, and previous antibiotics)
on the primary outcome measure, inpatient mortality.
CSF and plasma growth factors in children with bacterial
m e n i n g i t i s  w e r e  a n a l y z e d  b y  u s i n g  W i l c o x o n ' s  S i g n e d
Ranks test. Adjusted odds ratios (ORs) were obtained by
using logistic regression. All tests were two-tailed, and a P
value of < 0.05 was considered significant.
Results
Patient characteristics
We studied 293 children (57% boys), of whom 64 (22%)
died. The median age was 2.4 years, and the IQR, 0.7 to
6.0 years. The 211 (72%) children were first seen with
bacterial meningitis, and 82 (28%), with pneumonia; 154
(53%) children were HIV infected (50% of those with
meningitis, and 60% of those with pneumonia). Baseline
characteristics of study patients are shown in Table 1. In
total, 216 (74%) children had a serious bacterial infection
(SBI), and 77 had no organism identified (NBI). Of the
216 children with SBI, 182 (62%) had a gram-positive
organism, 33 (11%) had a gram-negative organism, and
one child had both gram-positive and -negative infec-
tions. The etiologies of both pneumonia and meningitis
are shown in Table 2.
Plasma VEGF, PDGF, and FGF in children with severe 
bacterial infection
Plasma VEGF, PDGF, and FGF on admission were signifi-
cantly elevated in children with severe bacterial infection
compared with healthy controls (Table 3). No significant
difference in plasma growth factors was found between
children with bacterial meningitis and those with pneu-
monia or between HIV-infected and HIV-uninfected
children. The mean plasma VEGF concentrations were
significantly higher in children with SBI compared with
those with NBI, and plasma concentrations of all threeM ankhambo et al. Critical Care 2010, 14:R91
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Table 1: Demographic, clinical, and laboratory characteristics of study patients by disease presentation
Meningitis Pneumonia P value
No. of patients 211 82
Age in years (median, IQR) 2.3 (0.6-6.0) 2.7 (0.9-5.6) NS
Gender (male) (%) 116 (55%) 52 (63%) NS
SBI (%) 176 (83%) 40 (49%) 0.0005
Gram-positive infection (%)a 146 (69%) 36 (44%) NS
Gram-negative infection (%)a 29 (14%) 4 (5%) NS
Blantyre Coma Score ≤2 (%) 88 (42%) 1 (1%) 0.0005
HIV infected (%) 105 (50%) 49 (60%) NS
Duration of symptoms in days (median, IQR) 3 (2-4) 3 (3-6) 0.001
Inpatient mortality (%) 58 (28%) 6 (7%) 0.0005
Wasting (weight-for-height Z score ≤3 SD) 33/172 (19%) 7/69 (10%) NS
Stunting (height-for-age Z score ≤3 SD) 31/206 (15%) 16/79 (20%) NS
White cell count (×109/L) (median, IQR) 11.8 (7.3-19.2) 15.7 (9.9-25.3) 0.001
C-reactive protein (mg/L) (median, IQR) 258 (162-323) 275 (56-345) NS
Glucose (mmol/L) (median, IQR) 6.1 (4.8-7.6) 5.2 (4.4-6.0) 0.0005
Lactate (mmol/L) (median, IQR) 3.9 (2.4-6.3) 2.6 (1.8-5.2) 0.006
Systolic BP(mm Hg) (median, IQR) 103 (93-115) 100 (89-110) NS
Diastolic BP(mm Hg) (median, IQR) 66 (59-80) 66 (59-76) NS
aOne child had mixed salmonella and pneumococcal infection (that is, mixed gram-positive and gram-negative infections). NS, not 
significant; P > 0.05.
growth factors were significantly higher in patients with
gram-positive than in those with gram-negative infec-
tions (Table 3). Mean plasma PDGF concentrations were
significantly higher in survivors compared with nonsurvi-
vors. VEGF, PDGF, and FGF concentrations were signifi-
c a n t l y  h i g h e r  i n  c h i l d r e n  w i t h  i n v a s i v e  p n e u m o c o c c a l
d i s e a s e  c o m p a r e d  w i t h  c h i l d r e n  w i t h  S B I  c a u s e d  b y
pathogens other than S. pneumoniae (Table 3). PDGF
concentrations were lower in children who had received
antibiotics before hospital admission (P = 0.02). No sig-
nificant differences were noted in mean VEGF, PDGF,
and FGF concentrations in children with wasting or
stunting and those without, and no correlation occurred
with duration of symptoms (data not shown).Mankhambo et al. Critical Care 2010, 14:R91
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CSF VEGF, PDGF, and FGF in children with bacterial 
meningitis
In 50 children with bacterial meningitis, CSF VEGF,
PDGF, and FGF were measured. CSF concentrations of
VEGF, PDGF, and FGF were significantly higher than
paired plasma concentrations (P = 0.001; P < 0.005; and P
< 0.0005, respectively, Wilcoxon signed rank test). No sig-
nificant correlations appeared between the CSF concen-
trations of VEGF, PDGF, or FGF and the CSF white cell
count, CSF absolute neutrophil count, or Blantyre coma
score. In children with pneumococcal meningitis (n = 30),
significant correlations were noted between CSF pneu-
mococcal bacterial load and the concentration of VEGF
and FGF in the CSF (Figure 1), and the CSF concentra-
tions of both of these growth factors were higher in
patients who died than in those who survived.
No significant differences were found in CSF VEGF,
PDGF, and FGF levels between children with coma (BCS
≤2) and those without. In contrast to plasma concentra-
tions, mean CSF, VEGF, and FGF concentrations were
higher in nonsurvivors than in survivors (1,178 versus
216 pg/ml; P = 0.02; and 939 versus 501 pg/ml; P = 0.001,
respectively).
Plasma Ang-1 and Ang-2 in children with severe bacterial 
sepsis
Plasma Ang-2 on admission was significantly increased in
children with severe bacterial infection compared with
healthy controls, but Ang-1 was not significantly different
(Table 3). No significant differences in Ang-1 and Ang-2
concentrations were noted between children with menin-
gitis and those with pneumonia, but Ang-2 was signifi-
cantly elevated in HIV-infected children. The mean
plasma Ang-1 concentrations were significantly lower in
children with SBI compared with those with NBI, but
Ang-2 was significantly higher after adjustment for con-
founding variables. Ang-1 and Ang-2 plasma concentra-
tions were not significantly different between gram-
positive and gram-negative infections (Table 3). Mean
plasma Ang-1 concentrations were significantly higher,
and Ang-2, significantly lower in survivors compared
with nonsurvivors (Table 3). The ratio of lnAng-2 (natu-
ral log Ang-2) to lnAng-1 was higher in nonsurvivors
compared with survivors (P = 0.03). Plasma Ang-1 con-
centrations were not significantly different in children
with invasive pneumococcal disease compared with chil-
dren with SBI caused by pathogens other than S. pneumo-
niae (Table 3). Plasma Ang-2 correlated positively with
the pro- and antiinflammatory cytokines, IL-1Ra, IL-6,
IL-8, and IL-10 (Table 4).
Logistic regression models for predicting mortality and SBI
The plasma values of VEGF, PDGF, FGF, Ang-1, and Ang-
2 were log transformed and included in a multivariate
stepwise logistic regression model, including HIV status,
sex, diagnosis (pneumonia or meningitis), and admission
Table 2: Etiology of pneumonia and meningitis
Organism Meningitis Pneumonia
Streptococcus pneumoniae 144 36
Neisseria meningitidis 10 0
Salmonella enterica serovar Typhimurium 51
Salmonella enterica serovar Enteritidis 20
Haemophilus influenzae b 73
Haemophilus influenzae 30
Mixed S. enterica/S. pneumoniae 10
Other (E. coli, K. pneumoniae, S. pyogenes, S. aureus)4 0
Negative 35 42
Total 211 82Mankhambo et al. Critical Care 2010, 14:R91
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lactate, as variables in the equation. Female sex (OR, 3.95;
95% CI, 1.33 to 11.76), and Ang-1 (OR, 0.23; 95% CI, 0.08
to 0.69) were significantly associated with mortality. By
using a similar model, meningitis (OR, 5.91; 95% CI, 1.47
to 23.77), admission lactate (OR, 3.20; 95% CI, 1.20 to
8.57), VEGF (OR, 5.63; 95% CI, 1.32 to 24.11), Ang-1 (OR,
0.19; 95% CI, 0.06 to 0.62), and Ang-2 (OR, 5.40; 95% CI,
1.79 to 16.30) were significantly associated with SBI
(Table 5).
Discussion
Our study examined both growth factors and angiogenic
factors in 293 children and demonstrates that among
Malawian children with severe bacterial infection, high
plasma VEGF, PDGF, FGF, and Ang-1 concentrations are
associated with a favorable outcome. In contrast, high
Ang-2 concentrations are associated with an unfavorable
outcome. In children with bacterial meningitis, our data
suggest intracerebral production of angiogenic factors,
and an association between high intrathecal concentra-
tions and mortality. Inpatient mortality is high in children
admitted with pneumonia and bacterial meningitis in
Malawi; therefore, it is important to determine the utility
of these angiogenic factors as biomarkers for the identifi-
cation of patients at risk of a poor outcome.
Our data are in keeping with current evidence that sug-
gests that the growth factors together with Ang-1 may be
involved in limiting the deleterious effects of sepsis-
Table 3: Summary of growth factors in Malawian children with sepsis
Geometric mean (25%-75% 
centile)
P values: univariable 
(multivariablea)
VEGF pg/ml PDGF pg/ml FGF pg/ml Ang1 1,000 pg/ml Ang2 1,000 pg/ml
Cases (n = 293) 90 (53-166) 956 (548-1884) 204 (119-376) 5.54 (2.6-9.7) 8.5 (5.2-13.6)
Controls (n = 15) 11 (4,15)
P < 0.001
402 (195-721)
P = 0.04
34 (20-48)
P < 0.001
6.84 (2.2-20.1)
P = 0.58
2.4 (1.6-4.6)
P < 0.001
NBI (n = 77) 77 (49-133) 1,069.4 (702-2,309) 210 (141-342) 8.4 (3.9-16.8) 5.3 (3.1-7.6)
SBI (n = 216) 96 (56-171)
P = 0.06 (0.02)
918 (521-1,779)
P = 0.27 (0.71)
202 (107-89)
P = 0.75 (0.74)
4.7 (2.4-8.7)
P < 0.001 (0.01)
10.0 (5.8-16.1)
P < 0.001 (0.002)
Gram-positive infection (n = 182) 102 (59-181) 978 (574-1,817) 215 (118-404) 4.8 (2.5-8.9) 10.4 (6.1-16.8)
Gram-negative infection (n = 33) 63 (40-96)
P = 0.004 (0.01)
643 (286-1,616)
P = 0.03 (0.03)
134 (84-278)
P = 0.007 (0.004)
4.2 (1.8-8.6)
P = 0.41 (0.54)
9.1 (5.7-14.2)
P = 0.23 (0.61)
Pneumonia (n = 211) 88 (54-155) 900 (528-1,756) 193 (116-356) 5.1 (2.5-9.6) 9.0 (5.3-15.8)
Meningitis (n = 82) 97 (51-200)
P = 0.38 (0.19)
1114 (676-2,378)
P = 0.11 (0.49)
239 (131-404)
P = 0.06 (0.15)
6.9 (3.7-14.6)
P = 0.10 (0.63)
7.0 (5.2-8.7)
P = 0.01 (0.52)
HIV negative (n = 138) 84 (53-145) 937 (547-1,720) 201 (117-377) 5.4 (2.7-9.7) 6.4 (3.9-9.2)
HIV positive (n = 154) 96 (53-177)
P = 0.17 (0.45)
967 (569-2,035)
P = 0.79 (0.95)
208 (123-375)
P = 0.71 (0.70)
5.7 (2.5-10.0)
P = 0.91 (0.72)
10.9 (6.2-16.8)
P < 0.001 (<0.001)
Survivors (n = 229) 93 (42-142) 1,051 (361-1,261) 214 (115-314) 6.0 (2.8-10.2) 7.7 (5.0-12.6)
Nonsurvivors (n = 64) 81 (54-176)
P = 0.27(0.19)
682 (612-2,035)
P = 0.003 (0.007)
171 (119-385)
P = 0.07 (0.10)
3.9 (2.3-7.4)
P = 0.03 (0.03)
11.9(6.7-21.7)
P = 0.001 (0.02)
Invasive pneumococcal disease 
(IPD) (n = 180)
101 (58-181) 978 (593-1,818) 215 (119-397) 4.8 (2.5-8.7) 10.4 (6.1-16.8)
SBI, other than IPD (n = 35) 68 (41-115)
P = 0.01
671 (292-1,611)
P = 0.04
146 (86-308)
P = 0.02
4.6 (2.0-9.1)
P = 0.32
8.3 (5.6-13.0)
P = 0.16
aMultivariable analyses included NBI/SBI, diagnosis(pneumonia/meningitis), HIV status, survival status and gram-positive/-negative type. (IPD/
SBI, other than IPD was not included in the model because of strong association with gram-positive/negative status. All except two of gram-
positive infections were IPD).Mankhambo et al. Critical Care 2010, 14:R91
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induced endothelial dysfunction. Consistent with previ-
ous work, growth-factor concentrations were signifi-
cantly higher in cases compared with controls. In
contrast to previous studies, which demonstrated highest
levels of growth factors in patients with septic shock
[24,25,27,29], we showed that levels were lower in those
with the most severe disease, defined as having a fatal
outcome. Very few of our patients demonstrated septic
shock or required aggressive fluid resuscitation. Our data
are consistent with those of Brueckmann et al. [26], who
demonstrated that adults with PDGF levels <200 pg/ml
were 7 times more likely to die than were those with
higher levels.
Karlsson et al. [28] demonstrated that VEGF concen-
trations in adult patients with sepsis were lower in non-
survivors than in survivors, but did not adequately
predict mortality. The differences in growth factors
between gram-positive and gram-negative infections are
difficult to explain. Our study was not designed to explain
this differential response. We speculate that differences in
the way bacterial cell components stimulate the inflam-
matory cascade might be responsible. We identified high
plasma Ang-1 concentrations and male gender as being
Figure 1 Scatterplot showing CSF VEGF and FGF against CSF pneumococcal bacterial load in children with pneumococcal meningitis.
Spearman’s r=0.46, p=0.01  Spearman’s r=0.55, p=0.02 
Table 4: Correlation between plasma angiogenic factors and pro- and antiinflammatory cytokines
Plasma IL-1Ra
(pg/ml)
Plasma IL-6
(pg/ml)
Plasma IL-8
(pg/ml)
Plasma IL-10
(pg/ml)
Plasma VEGF (pg/ml) NS NS 0.22
P < 0.0005
0.37
P < 0.0005
Plasma PDGF
(pg/ml)
-0.16
P = 0.06
NS NS NS
Plasma FGF
(pg/ml)
NS NS 0.13
P = 0.03
0.38
P < 0.0005
Plasma Ang-1
(pg/ml)
-0.37
P < 0.0005
-0.26
P < 0.0005
NS NS
Plasma Ang-2
(pg/ml)
0.53
P < 0.0005
0.44
P < 0.0005
0.50
P < 0.0005
0.34
P < 0.0005
NS, not significant.Mankhambo et al. Critical Care 2010, 14:R91
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independently associated with survival. Our study also
supports the concept of intracerebral production of
growth factors in bacterial meningitis.
The major limitation of our study was that we studied
growth-factor and angiopoietin concentrations only at
admission and did not follow their course over time.
Admission values are potentially more useful as prognos-
tic markers, if they can be made available to the clinician
at the time the patient is first seen, as they could help to
identify a group of patients requiring aggressive treat-
ment or characterize those eligible for entry to a random-
ized clinical trial of adjunctive therapies.
Interventions that target the inhibition of inflammatory
mediators and coagulation pathways have been unsuc-
cessful. Recently, microcirculatory dysfunction has been
shown to be a critical element of the pathogenesis of
severe sepsis [36]. The investigation of host mediators
that directly influence endothelial function might there-
fore be a valuable approach to improve our understand-
ing of the pathophysiology of sepsis.
A recent study demonstrated that activated protein C
(APC) uses the angiopoietin/Tie-2 axis to promote
endothelial barrier function [37]. Large clinical trials with
A P C  s h o w e d  a  b e n e f i c i a l  e f f e c t  i n  a d u l t  p a t i e n t s  w i t h
severe sepsis [38], but in children, this effect was not seen
[39]. Assessment of the angiopoietin/Tie-2 system might
help to identify those children who might benefit from
APC therapy or other new adjunctive therapies.
Our study contributes to the understanding of factors
controlling endothelial integrity, and our results are con-
sistent with those of previous studies [19,22,26,28].
Although the number of controls in our study was small,
the inclusion of a comparator group allows the assess-
ment of possible effects of other asymptomatic coinfec-
tions, such as helminths and malaria parasitemia. Three
studies in children have reported increased Ang-2 con-
centrations in severe malaria [40,41] and cerebral malaria
[41,42]. A recent study from Thailand [41] reported that
Ang-1 and Ang-2 discriminated severe from uncompli-
cated malaria, and Ang-1 distinguished children with
s e v e r e  m a l a r i a  f r o m  t h o s e  w i t h  c e r e b r a l  m a l a r i a .  T h e
authors propose that Ang-1 and Ang-2 are attractive can-
didates for a point-of-care test to identify individuals with
a risk of progression to severe disease, as they can be
incorporated into rapid lateral-flow immunochromato-
graphic tests such as those used in malaria diagnosis.
As our patient population differs significantly from
those of most of the readers of this journal, inferences
regarding other study populations may be difficult to
make. Nonetheless, we believe that the high mortality in
our patients represents the most severe end of the spec-
trum (that is, MODS without intensive care support),
which ultimately results from severe endothelial dysfunc-
tion. Although our study does not provide any descrip-
tion of multiorgan dysfunction, data from studies in
similar settings suggest that in severely ill children with-
Table 5: Multivariate logistic regression model to predict mortality and SBI
Predictor Adjusted OR for 
death
(95% CI)
P Adjusted OR for SBI
(95% CI)
P
Female sex 3.95 (1.33-11.76) 0.01 1.59 (0.47-5.42) 0.46
Meningitis 9.9 × 1012 1.0 5.91 (1.47-23.77) 0.01
HIV uninfected 0.60 (0.18-1.97) 0.4 1.18 (0.34-4.13) 0.8
Admission lactate 1.33 (0.52-3.37) 0.6 3.20 (1.20-8.57) 0.02
Plasma FGF (pg/ml) 1.35 (0.52-3.54) 0.5 0.94 (0.31-2.91) 0.92
Plasma VEGF (pg/ml) 1.21 (0.43-3.42) 0.7 5.63 (1.32-24.11) 0.02
Plasma PDGF (pg/ml) 3.17 (0.90-11.12) 0.07 1.07 (0.35-3.28) 0.91
Plasma Ang-1 (pg/ml) 0.23 (0.08-0.69) 0.009 0.19 (0.58-0.62) 0.006
Plasma Ang-2 (pg/ml) 0.90 (0.45-1.83) 0.6 5.40 (1.79-16.29) 0.003Mankhambo et al. Critical Care 2010, 14:R91
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out malaria, Blantyre Coma Score [43,44] and lactate [44]
accurately predict mortality.
The mobilization of endothelial progenitor cells (EPCs)
f r o m  b o n e  m a r r o w  t o  s i t e s  o f  e n d o t h e l i a l  i n j u r y  i s
induced by angiogenesis. A recent study demonstrated
that the number and function of EPCs decreased in the
progression of sepsis and may be one of the main patho-
genic factors in multiple organ dysfunction syndromes
[5]. EPCs are increased in the blood of patients with sep-
sis, in parallel with VEGF levels [45]. Our data support
the concept that the angiogenic factors reported here are
important in the pathophysiology of severe bacterial
infection.
Studies investigating host responses to infection have
shown that most mediators are increased and are posi-
tively associated with disease severity. We previously
showed that the concentration of the chemokine, Regu-
lated on Activation Normal T Cells Expressed and
Secreted (RANTES) is inversely associated with disease
severity in children, both in meningococcal disease [46]
and in pneumococcal disease [35]. Others confirmed this
finding in meningococcal disease [47]. This study now
adds another group of cytokines and angiopoietins that
are inversely associated with disease severity.
VEGF has been shown to be elevated in the CSF of chil-
dren and adults with bacterial meningitis [48] and in
adults with cryptococcal meningitis [49]. Both studies
suggest that the VEGF is produced intrathecally and may
contribute to the blood-brain barrier disruption. Our
data would also be consistent with intrathecal production
of growth factors. We demonstrated higher CSF than
plasma concentrations in paired samples, and higher con-
centrations of VEGF and FGF in the CSF of children who
died. We previously reported data that suggest a com-
partmentalized host response in pneumococcal meningi-
tis [33]. In contrast to the study by van der Flier [48], we
found no association between the CSF growth factors and
the CSF white cell count.
Neutrophils have been shown to secrete VEGF in
response to pneumococcal stimulation, and we suggest
that VEGF may play a role as a mediator of vascular per-
meability [50]. VEGF and PDGF are working in a complex
relation with Ang-1 and Ang-2 to promote endothelial
cell survival and to prevent apoptosis [17]. Our data
showing a favorable outcome in children with higher
plasma levels of FGF, VEGF, PDGF, and Ang-1 would be
consistent with this theory. Ang-2 appears to be acting as
an antagonist to the other angiogenic factors and corre-
lates positively with disease severity. The dysregulation of
Ang-1 and Ang-2 in severe sepsis may contribute to the
endothelial dysfunction and increased vascular permea-
bility that lead to multiorgan failure and mortality.
Conclusions
We have shown that low plasma VEGF, PDGF, FGF, and
Ang-1 concentrations are associated with an unfavorable
outcome in children with severe bacterial infection, the
association being independent of confounding factors in
the case of Ang-1. High Ang-2 concentrations are associ-
ated with mortality. In bacterial meningitis, our data sup-
port the concept of intracerebral production of growth
factors, with increased CSF concentrations in nonsurvi-
vors. VEGF, PDGF, FGF, Ang-1, and Ang-2 may be key
players in the endothelial dysregulation seen in severe
bacterial infection, or they may simply reflect an attempt
by the host to repair endothelial damage. The measure-
ment of these five factors might be useful (a) as prognos-
tic markers of outcome, and (b) in identifying children
who might benefit from adjunctive new therapies. Fur-
ther studies are needed to identify the exact mechanism
by which the angiopoietins might affect endothelial func-
tion in severe bacterial infection.
Key messages
• Mean VEGF, PDGF, and FGF concentrations are
higher in survivors than in nonsurvivors.
• Mean Ang-1 is significantly increased, and Ang-2
significantly decreased, in survivors compared with
nonsurvivors.
• Low Ang-1 is independently associated with mortal-
ity.
• In bacterial meningitis, mean CSF VEGF, PDGF, and
FGF concentrations were higher than paired plasma
concentrations, and mean CSF VEGF and FGF con-
centrations were higher in nonsurvivors than in survi-
vors.
• Ang-1 could be a useful prognostic marker.
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